Xin Lang Cai Jing·2025-09-29 11:32Core Points - Shanghai Junshi Biosciences Co., Ltd. announced a stock option incentive plan for 2025, proposing to grant a total of 25.965871 million rights [1] - The initial grant consists of 25.15 million options, accounting for 96.86% of the total, with Chairman Xiong Jun receiving 8 million options, representing 30.81% of the total options granted [1] - A total of 234 other incentive recipients will receive 17.15 million options, which is 66.05% of the total [1] - The reserved portion of the incentive plan is 815,871 options, making up 3.14% of the total [1] - The plan complies with relevant regulations, and the incentive recipients do not include independent directors, supervisors, or senior executives [1] - The reserved incentive recipients will be determined and disclosed within 12 months [1]